Gottlieb, A. B., Armstrong, A. W., Merola, J. F., Napoli, A. ., Nowak, M., Banerjee, S., Lehman, T. and Mease, P. J. (2024) “Impact of Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, Deucravacitinib, on Psoriasis in Patients with Active Psoriatic Arthritis: Results from a Phase 2 Trial”, SKIN The Journal of Cutaneous Medicine, 8(2), p. s383. doi: 10.25251/skin.8.supp.383.